copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
2017 Winter Newsletter- Biosimilar Interchangeability | Pharmacy . . . The draft guidance indicates that biosimilars will require physician approval before pharmacy substitution, unless they gain interchangeability status Interchangeable products may be substituted at the pharmacy without prescriber approval or notification
Pharmacogenetics: Pharmacy Evolution Patricia Milazzo, Rolls On Arvin . . . “integrating laboratory test results data, particularly ge-netic-based pharmacological eficacy data, into existing electronic systems like electronic health records, healthcare information exchanges, payor systems, self-insured employer groups, and pharmacy benefits manager systems ”
Nov-Dec_2019v05 - phsirx. com Easy access to care is valued by consumers CVS has expanded its telehealth services to 32 states and will continue to expand in rural areas where access to healthcare is not as readily available Rite Aid has partnered with InTouch Health and launched telehealth kiosks in several pharmacies
News Events | Pharmacy Healthcare Solutions, LLC. | Page 5 Setup your Online Health Record – Many insurance providers and doctor’s offices have online portals available where you can access information on your office visits, medications, vaccine history, diagnoses, lab results, and more
News Events | Pharmacy Healthcare Solutions, LLC. | Page 6 Founded in 1996, Pharmacy Healthcare Solutions provides pharmacy consulting solutions in a variety of areas including, but not limited to, product and program development, market research, operational efficiency, claims-data analysis, and training program construction www phsirx com
Publications | Pharmacy Healthcare Solutions, LLC. In their Viewpoints article, Don and Melissa share their predictions on what is to come for pharmacy in 2023, including changes in pharmacy business, drug prices, payment models, pharmacy participation in PBM networks, benefit designs, and biosimilar use